5PSQ-092 Analysis of off-label uses of inhalers in hospitalised patients

BACKGROUND: The high prevalence of respiratory diseases leads to high consumption of inhaled bronchodilators (IBs) not always appropriately indicated. It is important for patients and for the healthcare systems that a proper indication and use not only achieves greater efficacy and adherence to the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Villamañán, E, Freire, M, Sobrino, C, Jiménez, I, Lara, C, Ruano, M, Pérez, E, Jiménez, C, Rossignoli, A, Herrero, A
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535335/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.445
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares